Home
About
FAQ
History (13)
Left atrial systolic force and cardiac markers of preclinical disease in hypertensive patients: the Hypertension Genetic Epidemiology Network (HyperGEN) Study.
Cognition, Physical Function, and Quality of Life in Older Patients With Acute Decompensated Heart Failure.
High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression.
Exercise Intolerance in Older HFPEF Patients
Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.
Clark PE. Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer. Expert Rev Anticancer Ther. 2009 Jun; 9(6):821-30.
View in:
PubMed
subject areas
Chemotherapy, Adjuvant
Combined Modality Therapy
Disease Progression
Humans
Muscle Neoplasms
Neoadjuvant Therapy
Neoplasm Invasiveness
Risk Factors
Urinary Bladder Neoplasms
authors with profiles
Peter E. Clark MD